Global Neisseria meningitidis Infections Drug Market By Product Type (MGBBP-3, NCL-195) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984704
  • April 2021
  • Pharmaceuticals
  • 116 Pages

Report Preview

The global Neisseria meningitidis Infections Drug market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Neisseria meningitidis Infections Drug market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Neisseria meningitidis Infections Drug market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Neisseria meningitidis Infections Drug market.

Apart from this, the market research report also covers drivers and restraints for the global Neisseria meningitidis Infections Drug market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Neisseria meningitidis Infections Drug market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Neisseria meningitidis Infections Drug market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

XYZ Market Strategic Analysis:
In 2019, the global XYZ market was valued at US$ xx Mn, and it is expected to reach at US$ xx Mn at a CAGR of xx% during 2020-2028.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Neisseria meningitidis Infections Drug market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty. 
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type MGBBP-3, NCL-195, TP-10, Others
Applications Hospital, Clinic, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, Griffith University, ImmunoBiology Ltd, JN-International Medical Corp, MGB Biopharma Ltd, Panacea Biotec Ltd, Pfizer Inc, Sanofi Pasteur SA, Serum Institute of India Ltd, Wellstat Vaccines LLC

Neisseria meningitidis Infections Drug Market Segment Analysis:
The Neisseria meningitidis Infections Drug market research report segments the market based on its types, applications and end-use industry. All the segments of the market are analyzed and evaluated based on current and future trends of the market. The data for the segments and its categories is provided from 2018 to 2028. 

Neisseria meningitidis Infections Drug Market, by Type: MGBBP-3, NCL-195, TP-10, Others

Neisseria meningitidis Infections Drug Market, by Application: Hospital, Clinic, Others

Major Key Players for Global Neisseria meningitidis Infections Drug Market:
The Neisseria meningitidis Infections Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, Griffith University, ImmunoBiology Ltd, JN-International Medical Corp, MGB Biopharma Ltd, Panacea Biotec Ltd, Pfizer Inc, Sanofi Pasteur SA, Serum Institute of India Ltd, Wellstat Vaccines LLC

Geographic Coverage for Neisseria meningitidis Infections Drug Market:
The market research report on global Neisseria meningitidis Infections Drug market offers complete analysis across various regions across the world. The Neisseria meningitidis Infections Drug market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Neisseria meningitidis Infections Drug market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Neisseria meningitidis Infections Drug Market Value and Forecast
  • US
  • Canada

Europe Neisseria meningitidis Infections Drug Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe

Asia Pacific Neisseria meningitidis Infections Drug Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Neisseria meningitidis Infections Drug Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Neisseria meningitidis Infections Drug Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Key highlights of the Neisseria meningitidis Infections Drug market report:
  • The report provides key trends of the global Neisseria meningitidis Infections Drug market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Neisseria meningitidis Infections Drug industry
  • The report covers all the recent developments of the Neisseria meningitidis Infections Drug market and helps to provide current industry updates
  • The report covers a detailed look over the global Neisseria meningitidis Infections Drug Industry and provides with significant actionable insights
  • The Neisseria meningitidis Infections Drug market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Neisseria meningitidis Infections Drug market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Neisseria meningitidis Infections Drug market
  • Comprehensive analysis of the Neisseria meningitidis Infections Drug market segments based on its types, applications and end-use industry

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Neisseria meningitidis Infections Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Neisseria meningitidis Infections Drug market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Neisseria meningitidis Infections Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Neisseria meningitidis Infections Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Neisseria meningitidis Infections Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Neisseria meningitidis Infections Drug Market Snapshot
          2.1.1. Global Neisseria meningitidis Infections Drug Market By Type,2019
               2.1.1.1.MGBBP-3
               2.1.1.2.NCL-195
               2.1.1.3.TP-10
               2.1.1.4.Others
          2.1.2. Global Neisseria meningitidis Infections Drug Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Others
          2.1.3. Global Neisseria meningitidis Infections Drug Market By End-use,2019
          2.1.4. Global Neisseria meningitidis Infections Drug Market By Geography,2019

3. Global Neisseria meningitidis Infections Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028

5. Global Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028

6. Global Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Neisseria meningitidis Infections Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Neisseria meningitidis Infections Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Neisseria meningitidis Infections Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Neisseria meningitidis Infections Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Neisseria meningitidis Infections Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Neisseria meningitidis Infections Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Neisseria meningitidis Infections Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Neisseria meningitidis Infections Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Neisseria meningitidis Infections Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Neisseria meningitidis Infections Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Neisseria meningitidis Infections Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Neisseria meningitidis Infections Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Neisseria meningitidis Infections Drug Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Neisseria meningitidis Infections Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Neisseria meningitidis Infections Drug Providers
        8.4.1 Beijing Minhai Biotechnology Co Ltd
                8.1.1 Business Description
                8.1.2 Beijing Minhai Biotechnology Co Ltd Geographic Operations
                8.1.3 Beijing Minhai Biotechnology Co Ltd Financial Information
                8.1.4 Beijing Minhai Biotechnology Co Ltd Product Positions/Portfolio
                8.1.5 Beijing Minhai Biotechnology Co Ltd Key Developments
        8.4.2 Biological E Ltd
                8.2.1 Business Description
                8.2.2 Biological E Ltd Geographic Operations
                8.2.3 Biological E Ltd Financial Information
                8.2.4 Biological E Ltd Product Positions/Portfolio
                8.2.5 Biological E Ltd Key Developments
        8.4.3 China National Pharmaceutical Group Corp
                8.3.1 Business Description
                8.3.2 China National Pharmaceutical Group Corp Geographic Operations
                8.3.3 China National Pharmaceutical Group Corp Financial Information
                8.3.4 China National Pharmaceutical Group Corp Product Positions/Portfolio
                8.3.5 China National Pharmaceutical Group Corp Key Developments
        8.4.4 GlaxoSmithKline Plc
                8.4.1 Business Description
                8.4.2 GlaxoSmithKline Plc Geographic Operations
                8.4.3 GlaxoSmithKline Plc Financial Information
                8.4.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.4.5 GlaxoSmithKline Plc Key Developments
        8.4.5 Griffith University
                8.5.1 Business Description
                8.5.2 Griffith University Geographic Operations
                8.5.3 Griffith University Financial Information
                8.5.4 Griffith University Product Positions/Portfolio
                8.5.5 Griffith University Key Developments
        8.4.6 ImmunoBiology Ltd
                8.6.1 Business Description
                8.6.2 ImmunoBiology Ltd Geographic Operations
                8.6.3 ImmunoBiology Ltd Financial Information
                8.6.4 ImmunoBiology Ltd Product Positions/Portfolio
                8.6.5 ImmunoBiology Ltd Key Developments
        8.4.7 JN-International Medical Corp
                8.7.1 Business Description
                8.7.2 JN-International Medical Corp Geographic Operations
                8.7.3 JN-International Medical Corp Financial Information
                8.7.4 JN-International Medical Corp Product Positions/Portfolio
                8.7.5 JN-International Medical Corp Key Developments
        8.4.8 MGB Biopharma Ltd
                8.8.1 Business Description
                8.8.2 MGB Biopharma Ltd Geographic Operations
                8.8.3 MGB Biopharma Ltd Financial Information
                8.8.4 MGB Biopharma Ltd Product Positions/Portfolio
                8.8.5 MGB Biopharma Ltd Key Developments
        8.4.9 Panacea Biotec Ltd
                8.9.1 Business Description
                8.9.2 Panacea Biotec Ltd Geographic Operations
                8.9.3 Panacea Biotec Ltd Financial Information
                8.9.4 Panacea Biotec Ltd Product Positions/Portfolio
                8.9.5 Panacea Biotec Ltd Key Developments
        8.4.10 Pfizer Inc
                8.10.1 Business Description
                8.10.2 Pfizer Inc Geographic Operations
                8.10.3 Pfizer Inc Financial Information
                8.10.4 Pfizer Inc Product Positions/Portfolio
                8.10.5 Pfizer Inc Key Developments
        8.4.11 Sanofi Pasteur SA
                8.11.1 Business Description
                8.11.2 Sanofi Pasteur SA Geographic Operations
                8.11.3 Sanofi Pasteur SA Financial Information
                8.11.4 Sanofi Pasteur SA Product Positions/Portfolio
                8.11.5 Sanofi Pasteur SA Key Developments
        8.4.12 Serum Institute of India Ltd
                8.12.1 Business Description
                8.12.2 Serum Institute of India Ltd Geographic Operations
                8.12.3 Serum Institute of India Ltd Financial Information
                8.12.4 Serum Institute of India Ltd Product Positions/Portfolio
                8.12.5 Serum Institute of India Ltd Key Developments
        8.4.13 Wellstat Vaccines LLC
                8.13.1 Business Description
                8.13.2 Wellstat Vaccines LLC Geographic Operations
                8.13.3 Wellstat Vaccines LLC Financial Information
                8.13.4 Wellstat Vaccines LLC Product Positions/Portfolio
                8.13.5 Wellstat Vaccines LLC Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Neisseria meningitidis Infections Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Neisseria meningitidis Infections Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Neisseria meningitidis Infections Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Neisseria meningitidis Infections Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Neisseria meningitidis Infections Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Neisseria meningitidis Infections Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Neisseria meningitidis Infections Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Neisseria meningitidis Infections Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Neisseria meningitidis Infections Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Neisseria meningitidis Infections Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Neisseria meningitidis Infections Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Neisseria meningitidis Infections Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Neisseria meningitidis Infections Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Neisseria meningitidis Infections Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Neisseria meningitidis Infections Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Neisseria meningitidis Infections Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Neisseria meningitidis Infections Drug: Market Segmentation 
FIG. 2 Global Neisseria meningitidis Infections Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Neisseria meningitidis Infections Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Neisseria meningitidis Infections Drug Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Neisseria meningitidis Infections Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Neisseria meningitidis Infections Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Neisseria meningitidis Infections Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Neisseria meningitidis Infections Drug Providers, 2019
FIG. 11 Global Neisseria meningitidis Infections Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Neisseria meningitidis Infections Drug Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Neisseria meningitidis Infections Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Neisseria meningitidis Infections Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Neisseria meningitidis Infections Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Neisseria meningitidis Infections Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Neisseria meningitidis Infections Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Neisseria meningitidis Infections Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Neisseria meningitidis Infections Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Neisseria meningitidis Infections Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Neisseria meningitidis Infections Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Neisseria meningitidis Infections Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Neisseria meningitidis Infections Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Neisseria meningitidis Infections Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Neisseria meningitidis Infections Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Neisseria meningitidis Infections Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Neisseria meningitidis Infections Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Neisseria meningitidis Infections Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Neisseria meningitidis Infections Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Neisseria meningitidis Infections Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Neisseria meningitidis Infections Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Neisseria meningitidis Infections Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Neisseria meningitidis Infections Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Neisseria meningitidis Infections Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Neisseria meningitidis Infections Drug Market Value, By Country, 2018 – 2028
TABLE  Beijing Minhai Biotechnology Co Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biological E Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  China National Pharmaceutical Group Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Griffith University: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ImmunoBiology Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JN-International Medical Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MGB Biopharma Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Panacea Biotec Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi Pasteur SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Serum Institute of India Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wellstat Vaccines LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Neisseria meningitidis Infections Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Neisseria meningitidis Infections Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Neisseria meningitidis Infections Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Neisseria meningitidis Infections Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Neisseria meningitidis Infections Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Neisseria meningitidis Infections Drug Providers, 2016
FIG.  Global Neisseria meningitidis Infections Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global MGBBP-3 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NCL-195 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global TP-10 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neisseria meningitidis Infections Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Neisseria meningitidis Infections Drug Market Value, 2018 – 2028, (US$ Mn)